Strs Ohio Novavax Inc Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Novavax Inc stock. As of the latest transaction made, Strs Ohio holds 26,100 shares of NVAX stock, worth $227,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,100

Previous 26,100 -0.0%

Holding current value

$227,069

Previous $330,000 0.3%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$3.89 - $20.97 $331,428 - $1.79 Million	-85,200 Reduced 76.55%	26,100 $330,000
Q1 2024 May 13, 2024	BUY	$3.76 - $6.02 $41,736 - $66,822	11,100 Added 11.08%	111,300 $532,000
Q4 2023 Jan 30, 2024	BUY	$4.8 - $7.67 $94,560 - $151,099	19,700 Added 24.47%	100,200 $480,000
Q3 2023 Oct 26, 2023	SELL	$6.81 - $9.74 $27,240 - $38,960	-4,000 Reduced 4.73%	80,500 $582,000
Q2 2023 Jul 31, 2023	BUY	$6.67 - $9.52 $563,615 - $804,440	84,500 New	84,500 $627,000
Q2 2022 Jul 25, 2022	SELL	$36.28 - $75.29 $156,004 - $323,747	-4,300 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$69.73 - $142.9 $299,839 - $614,470	4,300 New	4,300 $316,000
Q4 2021 Jan 24, 2022	SELL	$134.56 - $217.97 $458,311 - $742,405	-3,406 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$177.8 - $270.58 $605,586 - $921,595	3,406 New	3,406 $706,000
Q2 2021 Jul 26, 2021	SELL	$121.0 - $257.67 $1.71 Million - $3.63 Million	-14,100 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$112.98 - $319.93 $248,556 - $703,846	2,200 Added 18.49%	14,100 $2.56 Million
Q4 2020 Jan 25, 2021	BUY	$78.74 - $139.5 $39,370 - $69,750	500 Added 4.39%	11,900 $1.33 Million
Q3 2020 Dec 14, 2020	BUY	$79.44 - $178.51 $238,320 - $535,530	3,000 Added 35.71%	11,400 $1.24 Million
Q2 2020 Jul 23, 2020	BUY	$13.86 - $83.61 $116,424 - $702,324	8,400 New	8,400 $700,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account